Covid, Irbm: “In November, first doses of the vaccine to Italy if the tests are positive”

“The first 2-3 million doses of the Covid Oxford-Irbm-AstraZeneca vaccine should arrive in Italy by the end of November if the ongoing trial progresses positively, after the temporary suspension due to a suspicious reaction in a volunteer that turned out to be unrelated to the vaccine candidate. Says it toAnsa Piero di Lorenzo, president of the Irbm of Pomezia, which collaborated with the Jenner Institute at the University of Oxford to develop the vaccine prototype. “If there are no critical problems and experimentation continues as planned, therefore, the time already announced by the Minister of Health will be respected,” he added. Roberto Speranza ». “The doses – he adds – will be delivered to the Italian government”, which will probably use them to some categories at risk such as healthcare workers and the elderly hospitalized in RSA.